Search Results - "De Lorenzo, A. García"

The burden of hospital malnutrition in Spain: methods and development of the PREDyCES® study by Planas Vila, M, Álvarez Hernández, J, García de Lorenzo, A, Celaya Pérez, S, León Sanz, M, García-Lorda, P, Brosa, M

“…It is well known that hospital malnutrition is a highly prevalent condition associated to increase morbidity and mortality as well as related healthcare costs…”
Get full text

Early acute kidney injury in severe burns by Flores Cabeza, E., Sanchez-Sanchez, M., Cachafeiro Fuciños, L., García de Lorenzo, A.

Get full text

The importance of the coding of hospital malnutrition in the health strategy of the European Union: a Spanish contribution by Álvarez, J, León, M, Planas, M, García de Lorenzo, A

“…Malnutrition related to illness and inadequate nutrition remains a matter of relevant interest in the member countries of the European Union because of its…”
Get full text

Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries by Asensio, M. J., Sánchez, M., Galván, B., Herrero, E., Cachafeiro, L., Agrifoglio, A., Perales, E., Luque, S., García-de-Lorenzo, A.

Get full text

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey by Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C., Linhart, A., Sunder-Plassmann, G., Ries, M., Beck, M.

“…Background  Fabry disease is a rare X‐linked disorder caused by deficient activity of the lysosomal enzyme α‐galactosidase A. Progressive accumulation of the…”
Get full text

Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection by García-de-Lorenzo, A, Luque, S, Grau, S, Agrifoglio, A, Cachafeiro, L, Herrero, E, Asensio, M J, Sánchez, S M, Roberts, J A

“…Severely burned patients have altered drug pharmacokinetics (PKs), but it is unclear how different they are from those in other critically ill patient groups…”
Get full text

Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols by García-de-Lorenzo, A., Denia, R., Atlan, P., Martinez-Ratero, S., Le Brun, A., Evard, D., Bereziat, G.

“…It has been claimed that lipid emulsions with a restricted linoleic acid content can improve the safety of total parenteral nutrition (TPN). The tolerability…”
Get full text

Effect of the route of nutrition and l-alanyl-l-glutamine supplementation in amino acids’ concentration in trauma patients by Raurich, J. M., Llompart-Pou, J. A., García-de-Lorenzo, A., Buño Soto, A., Marsé, P., Frontera, G., Pérez-Bárcena, J.

“…Purpose Our purpose was to assess the amino acids’ (AAs) profile in trauma patients and to assess the effect of the route of nutrition and the exogenous…”
Get full text

First resuscitation of critical burn patients: progresses and problems by Sánchez-Sánchez, M, García-de-Lorenzo, A, Asensio, M.J

“…Abstract Currently, the aim of the resuscitation of burn patients is to maintain end-organ perfusion with fluid intake as minimal as possible. To avoid excess…”
Get full text

Fabry disease: overall effects of agalsidase alfa treatment by Beck, M., Ricci, R., Widmer, U., Dehout, F., De Lorenzo, A. García, Kampmann, C., Linhart, A., Sunder-Plassmann, G., Houge, G., Ramaswami, U., Gal, A., Mehta, A.

“…Background  Fabry disease is a rare X‐linked disorder caused by deficient activity of the lysosomal enzyme α‐galactosidase A. Progressive accumulation of the…”
Get full text

Prevalence and costs of malnutrition in hospitalized patients; the PREDyCES Study by Álvarez-Hernández, J, Planas Vila, M, León-Sanz, M, García de Lorenzo, A, Celaya-Pérez, S, García-Lorda, P, Araujo, K, Sarto Guerri, B

“…The main objective of the PREDyCES study was twofold. First, to analyse the prevalence of hospital malnutrition in Spain, both at admission and at discharge,…”
Get full text

Critically ill patients with COVID-19 and candidaemia: We must keep this in mind by Agrifoglio, A., Cachafeiro, L., Figueira, J.C., Añón, J.M., García de Lorenzo, A.

Get full text

Chronic critical illness, how to manage it? by García-de-Lorenzo, A., Añón, J.M., Asensio, M.J., Burgueño, P.

Get full text

Intensive care during the 2019-coronavirus epidemic by González-Castro, A, Escudero-Acha, P, Peñasco, Y, Leizaola, O, Martínez de Pinillos Sánchez, V, García de Lorenzo, A

“…On 31 December 2019, the Health Commission of Hubei Province of China first unveiled a group of unexplained cases of pneumonia, which WHO subsequently defined…”
Get full text

Prognosis of patients with COPD admitted to the ICU by Añón, J M, de Lorenzo, A García

Get more information

Multidisciplinary rounds in oncology and hematology: Are they superior to rapid response teams? by García-de-Lorenzo, A, Jiménez, V, Feliu, J, Asensio, M J, Civantos, B, Añón, J M

Get full text

Document on the state of affairs of the Spanish model of Intensive Care Medicine. SEMICYUC Strategic Plan 2018-2022 by Olaechea Astigarraga, P M, Bodí Saera, M, Martín Delgado, M C, Holanda Peña, M S, García de Lorenzo Y Mateos, A, Gordo Vidal, F

Get full text

Intensive care during the 2019-coronavirus epidemic by González-Castro, A., Escudero-Acha, P., Peñasco, Y., Leizaola, O., Martínez de Pinillos Sánchez, V., García de Lorenzo, A.

“…On 31 December 2019, the Health Commission of Hubei Province of China first unveiled a group of unexplained cases of pneumonia, which WHO subsequently defined…”
Get full text

SUN-PP197: Agreement between the Screening Tools SNAQ and MNA-SF in Elderly People in Madrid. Dream+65 Study by Alvarez, J, Cuerda, C, Ramos, P, Abanades, J.C, García de Lorenzo, A, Gil, P, de la Cruz, J.J

Get full text

Cutaneous mucormycosis in the ICU by Herrero, EH, Sánchez, M, Agrifoglio, A, Cachafeiro, L, Asensio, MJ, Galván, B, de Lorenzo, A García

“…Keywords: Fungal Infection, Antibiotic Treatment, Descriptive Study, Antifungal Therapy, Procalcitonin…”
Get full text